escitalopram
Showing 1 - 25 of 270
MDD Trial in Islamabad (Sertraline, Escitalopram)
Completed
- Major Depressive Disorder
- Sertraline
- Escitalopram
-
Islamabad, PakistanKRL Hospital
Jul 14, 2023
Major Depression Trial in Atlanta (Bupropion XL, Escitalopram)
Recruiting
- Major Depression
- Bupropion XL
- Escitalopram
-
Atlanta, GeorgiaEmory Clinic
Jan 23, 2023
Depression, Parkinson Disease Trial (Nortriptyline, Escitalopram, Placebo)
Recruiting
- Depression
- Parkinson Disease
- Nortriptyline
- +2 more
-
London, United KingdomRoyal Free London NHS Foundation Trust
Nov 2, 2022
Pancreatic Ductal Adenocarcinoma, Periampullary Cancer Trial in Cleveland (Escitalopram, Placebo)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Periampullary Cancer
- Escitalopram
- Placebo
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center
Aug 8, 2022
Bariatric Surgery and Pharmacokinetics of Escitalopram
Recruiting
- Obesity, Morbid
- Escitalopram
-
Trondheim, NorwaySt. Olavs University Hospital
Mar 21, 2022
OCD, Healthy Individuals Trial in Copenhagen (Escitalopram, Placebo oral tablet)
Recruiting
- Obsessive-Compulsive Disorder/High Compulsive Individuals
- Healthy Individuals
- Escitalopram
- Placebo oral tablet
-
Copenhagen, DenmarkNeurobiology Research Unit, Rigshospitalet
Nov 17, 2022
Sperm DNA Fragmentation, Infertility, Male Trial in New York (Escitalopram, Placebo)
Recruiting
- Sperm DNA Fragmentation
- Infertility, Male
- Escitalopram
- Placebo
-
New York, New YorkWeill Cornell Medicine
Apr 29, 2022
Outpatients / Inpatients With Depression Trial in Beijing (Escitalopram, Escitalopram+Aripiprazole, Escitalopram+omega-3 PUFAs)
Not yet recruiting
- Outpatients / Inpatients With Depression
- Escitalopram
- +3 more
-
Beijing, Beijing, China
- +2 more
Sep 27, 2022
Anxiety Trial in Cincinnati (Escitalopram)
Recruiting
- Anxiety
- Escitalopram
-
Cincinnati, OhioUniversity of Cincinnati, Department of Psychiatry & Behavioral
Feb 14, 2022
Personalized Escitalopram Dosing in Patients With Depression
Recruiting
- Depressive Disorder, Major
- Escitalopram
-
Belgrade, Serbia
- +2 more
Jan 13, 2022
MDD Trial in Shanghai (dietary supplement, device, drug)
Recruiting
- Major Depressive Disorder
- Escitalopram+Sulforaphane
- +2 more
-
Shanghai, ChinaShanghai Mental Health Center
Dec 2, 2021
Anxiety, Depressive Symptoms Trial in Cincinnati (Duloxetine, Escitalopram)
Recruiting
- Anxiety
- Depressive Symptoms
- Duloxetine
- Escitalopram
-
Cincinnati, OhioUniversity of Cincinnati
Feb 14, 2022
MDD (MDD) Trial (Aripiprazole, Escitalopram)
Terminated
- Major Depressive Disorder (MDD)
- Aripiprazole
- Escitalopram
- (no location specified)
Nov 24, 2021
Depression Trial in Stony Brook (Escitalopram, Placebo)
Completed
- Depression
- Escitalopram
- Placebo
-
Stony Brook, New YorkStony Brook University Hospital
Dec 14, 2022
Anxiety Disorders, Generalized Anxiety Disorder, Panic Disorder Trial in Washington, Boston, New York (Mindfulness-Based Stress
Completed
- Anxiety Disorders
- +4 more
- Mindfulness-Based Stress Reduction
- Escitalopram
-
Washington, District of Columbia
- +2 more
Jan 7, 2022
Study to Explore Antidepressant Treatment in Korea
Completed
- Major Depression
- Escitalopram
- +10 more
-
Seoul, Korea, Republic ofPfizer
Nov 14, 2022
Depression Trial in Changsha (Escitalopram, Game intervention)
Recruiting
- Depression
- Escitalopram
- Game intervention
-
Changsha, ChinaThe Second Xiangya Hospital of Central South University
Jul 19, 2022
Anxious Depression, Depression Trial in Cincinnati (Escitalopram, Duloxetine)
Recruiting
- Anxious Depression
- Depression
- Escitalopram
- Duloxetine
-
Cincinnati, OhioUniversity of Cincinnati, Department of Psychiatry & Behavioral
Feb 14, 2022
Depression, Anxiety, Bipolar Disorder Trial in Stanford, Cincinnati (Escitalopram, Cognitive behavioral Psychotherapy)
Active, not recruiting
- Depression
- +2 more
- Escitalopram
- Cognitive behavioral Psychotherapy
-
Stanford, California
- +1 more
Feb 25, 2022
MDD Trial in Austin (Centanafadine (328.8 mg), Escitalopram, Placebo)
Recruiting
- Major Depressive Disorder
- Centanafadine (328.8 mg)
- +2 more
-
Austin, TexasFor additional information regarding sites, contact 844-687-8522
Sep 14, 2022
MDD Trial (Vortioxetine, Sertraline, citalopram)
Active, not recruiting
- Major Depressive Disorder
- Vortioxetine
- +6 more
-
Catanzaro, Italy
- +2 more
Oct 7, 2022
Post Traumatic Stress Disorder, MDD Trial in New York (Escitalopram, Duloxetine)
Terminated
- Post Traumatic Stress Disorder
- Major Depressive Disorder
- Escitalopram
- Duloxetine
-
New York, New YorkNew York State Psychiatric Institute
Apr 12, 2022
Mild-to-moderate Depression Trial in China (TECAS Procedure, Escitalopram, Insomnia medication)
Recruiting
- Mild-to-moderate Depression
- TECAS Procedure
- +2 more
-
Shenzhen, Guangdong, China
- +5 more
Nov 24, 2021